P12Q (p.Pro12Gln) variant of IRS2 (Insulin receptor substrate 2)

P12Q (p.Pro12Gln) in IRS2 (Insulin receptor substrate 2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.13 / 1. The record also includes population frequency data and structural context.

P12Q (p.Pro12Gln) variant details